Standardized versus individualized parenteral nutrition in very low birth weight infants: a comparative study

Tatiana Smolkin1, Giselle Diab, Irit Shohat

  • 1Department of Neonatology, Meyer Children's Hospital, Rambam Health Care Campus, Bat-Galim, Haifa, Israel.

Neonatology
|March 18, 2010
PubMed

Insights

Individualized parenteral nutrition (IPN) in very low birth weight (VLBW) infants promotes better growth and requires fewer electrolyte corrections than standard parenteral nutrition (SPN). IPN is optimal for VLBW infants, though SPN remains a viable alternative.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Intensive Care Medicine

Background:

  • Parenteral nutrition (PN) is crucial for the growth and outcomes of very low birth weight (VLBW) infants.
  • The optimal composition of PN, whether standard (STD-PN) or individualized (IND-PN), remains a subject of debate.
  • This study aims to resolve this controversy by comparing IND-PN and STD-PN.

Purpose of the Study:

  • To compare individualized parenteral nutrition (IND-PN) with standard parenteral nutrition (STD-PN) in VLBW infants.
  • To evaluate differences in nutritional parameters, growth, complications, and cost between IND-PN and STD-PN.
  • To determine the optimal PN strategy for VLBW infants.

Main Methods:

  • A cohort of 140 VLBW infants was studied, with 70 neonates in the IND-PN group matched to 70 neonates in the STD-PN group based on gestational age (GA; +/-4 days).
  • Data collected included demographic, maternal, intrapartum, neonatal, interventional, growth, and nutritional parameters.
  • Statistical analysis was performed to compare outcomes between the two groups.

Main Results:

  • IND-PN infants exhibited significantly greater weight gain SDS during the first week (p = 0.036) and first month (p = 0.0004) compared to STD-PN infants.
  • IND-PN infants showed higher discharge weight SDS (p = 0.012) and head circumference SDS (p = 0.006).
  • IND-PN infants received higher mean daily caloric intakes, had shorter durations of exclusive PN, and required fewer electrolyte corrections.

Conclusions:

  • IND-PN leads to significantly better growth in VLBW infants compared to STD-PN, without increased clinical or laboratory complications.
  • IND-PN resulted in a shorter period of exclusive PN and reduced need for electrolyte corrections.
  • IND-PN aligns with an aggressive nutritional approach and appears optimal for VLBW infants, although adequately composed STD-PN is a suitable alternative.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...